Vistin Pharma ASA Cash Flow Quality Index
Vistin Pharma ASA cash flow quality index. Vistin Pharma ASA (VISTN) has a Cash Flow Quality Index of -0.17x as of March 2026. Operating cash flow of Nkr-3.67 Million is below net income of Nkr21.49 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore VISTN operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Vistin Pharma ASA (2016–2025)
Cash flow quality index of Vistin Pharma ASA from 2016 to 2025. Historical Cash Flow Quality Index for Vistin Pharma ASA across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. See Vistin Pharma ASA balance sheet independence to measure how much of total assets are equity-financed.
Vistin Pharma ASA Cash Flow Quality Index by Year (2016–2025)
Vistin Pharma ASA cash flow quality index by year from 2016 to 2025. Year-by-year earnings quality comparison for Vistin Pharma ASA. For the full cash flow conversion analysis, see cash flow conversion of Vistin Pharma ASA.
| Year | Quality Index | Operating CF (NOK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.04x | Nkr78.04 Million | Nkr74.75 Million | ▼ -22.1% |
| 2024 | 1.34x | Nkr107.86 Million | Nkr80.45 Million | ▼ -13.4% |
| 2023 | 1.55x | Nkr90.59 Million | Nkr58.52 Million | ▲ +181.4% |
| 2021 | 0.55x | Nkr13.68 Million | Nkr24.87 Million | ▲ +92.4% |
| 2019 | 0.29x | Nkr18.93 Million | Nkr66.20 Million | ▲ +111.8% |
| 2017 | 0.14x | Nkr9.51 Million | Nkr70.40 Million | ▼ -96.8% |
| 2016 | 4.17x | Nkr53.84 Million | Nkr12.92 Million | — |